« Back to Farmacia Journal 4/2023
AWARENESS AND RECOMMENDATION RELATED TO DPYD TESTING AMONG MEDICAL ONCOLOGISTS IN ROMANIA: A SURVEY STUDY
ANDRADA LARISA DEAC 1*, DANIEL SUR 2, ALECSANDRA GORZO 2, CRISTIAN-VIRGIL LUNGULESCU 3, CLAUDIA-CRISTINA BURZ 4, LOREDANA BĂLĂCESCU 2, ELENA ADRIANA DUMITRESCU 5, DANA LUCIA STĂNCULEANU 5, ANCA-DANA BUZOIANU 1
1Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, “Iuliu Hațieganu" University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania
2“Prof. Dr. Ion Chiricuţă" Institute of Oncology, 400125, Cluj-Napoca, Romania
3Department of Oncology, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania
4Department of Immunology and Allergology, Faculty of Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania
5Department of Oncology, "Carol Davila" University of Medicine and Pharmacy, 050474, Bucharest, Romania